Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.

Vernon, S M

Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes. [electronic resource] - Cardiology clinics May 2001 - 235-52, vi p. digital

Publication Type: Journal Article; Review

0733-8651

10.1016/s0733-8651(05)70210-1 doi


Abciximab
Angina, Unstable--drug therapy
Antibodies, Monoclonal--adverse effects
Coronary Artery Bypass
Dalteparin--therapeutic use
Enoxaparin--therapeutic use
Eptifibatide
Fibrinolytic Agents--therapeutic use
Hemorrhage--chemically induced
Heparin, Low-Molecular-Weight--adverse effects
Humans
Immunoglobulin Fab Fragments--adverse effects
Myocardial Infarction--drug therapy
Nadroparin--therapeutic use
Peptides--adverse effects
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--adverse effects
Thrombocytopenia--chemically induced
Thrombosis--chemically induced
Tirofiban
Transaminases--blood
Tyrosine--adverse effects